These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 11398841

  • 1. Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration.
    Ishizawa K, Dickson DW.
    J Neuropathol Exp Neurol; 2001 Jun; 60(6):647-57. PubMed ID: 11398841
    [Abstract] [Full Text] [Related]

  • 2. Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I, Blanco R, Carmona M, Ribera R, Goutan E, Puig B, Rey MJ, Cardozo A, Viñals F, Ribalta T.
    Brain Pathol; 2001 Apr; 11(2):144-58. PubMed ID: 11303790
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.
    Dickson DW.
    J Neurol; 1999 Sep; 246 Suppl 2():II6-15. PubMed ID: 10525997
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration.
    Mimuro M, Yoshida M.
    Neuropathology; 2020 Feb; 40(1):57-67. PubMed ID: 31515852
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
    Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, Parisi JE, Dickson DW.
    Neurology; 2006 Jan 10; 66(1):41-8. PubMed ID: 16401843
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Staging disease severity in movement disorder tauopathies: brain atrophy separates progressive supranuclear palsy from corticobasal degeneration.
    Schofield EC, Caine D, Kril JJ, Cordato NJ, Halliday GM.
    Mov Disord; 2005 Jan 10; 20(1):34-9. PubMed ID: 15390131
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.